Breaking News
Get 45% Off 0
🚨 Don’t miss your updated list of AI-picked stocks for this month
Pick Stocks with AI

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
Magellan (MMP) & Plains All To Increase BridgeTex Capacity By Zacks Investment Research - Nov 30, 2017

Magellan Midstream Partners, L.P. (NYSE:MMP) along with Plains All American Pipeline, L.P. (NYSE:PAA) , its joint venture partner in BridgeTex Pipeline Company, LLC, announced plans to increase the...

Zacks Investment Research
Paychex Hits 52-Week High, Expanding Customer Base Holds Key By Zacks Investment Research - Nov 30, 2017

Shares of Paychex, Inc. (NASDAQ:PAYX) touched a 52-week high of $67.88, eventually closing at $67.31 on Nov 30, 2017. The stock has gained 10.6% year to date, substantially outperforming the 6.1%...

Zacks Investment Research
FLR, PWR Or ACM: Which Engineering Stock To Buy Now? By Zacks Investment Research - Nov 30, 2017

Construction sector stocks have performed well in the past six months, with the sector gaining 16.7% on average, more than double the S&P 500’s gain of 8.1%. We believe growth-conducive...

Zacks Investment Research
Company News For Dec 1, 2017 By Zacks Investment Research - Nov 30, 2017

Shares of Kroger Co. (NYSE:KR) surged 6.1% after posting third quarter 2017 earnings $0.44 a share, surpassing the Zacks Consensus Estimate of $0.40L Brands, Inc.’s (NYSE:LB) shares surged...

Zacks Investment Research
BioTelemetry's (BEAT) Telcare Unit Collaborates With Onduo By Zacks Investment Research - Nov 30, 2017

BioTelemetry, Inc.’s (NASDAQ:BEAT) Telcare division recently signed a partnership agreement with Onduo — a joint venture by Verily (an Alphabet (NASDAQ:GOOGL) company) and Sanofi...

Zacks Investment Research
3 Top Principal Mutual Funds To Buy Now By Zacks Investment Research - Nov 30, 2017

Principal Financial Group (NYSE:PFG) is a renowned publicly owned global investment management firm focused on offering financial tools, resources and information to investors. The Des Moines, IA...

Zacks Investment Research
Cancer Space Update: Pfizer's Bavencio Fails In Phase III By Zacks Investment Research - Nov 30, 2017

There was no major news in the cancer space this week, except the failure of Pfizer Inc.’s (NYSE:PFE) Bavencio in a gastric cancer study. In a setback to Eisai Co., Ltd. (OTC:ESALY) ,...

Zacks Investment Research
What Can Target Learn From Wal-Mart's Retail Game? By Zacks Investment Research - Nov 30, 2017

In early November, reports emerged that Target Corporation (NYSE:TGT) was looking to shutter a dozen stores by February next year. A spokesperson for the company commented that this was part of an...

Alex Newman
EA Stocks Plunge After Battlefront II Disaster By Alex Newman - Nov 30, 2017

Financial markets are giving Electronic Arts Inc (NASDAQ:EA) stocks the cold shoulder after a marketing fiasco revolving around Battlefront II, a videogame developed by the company, resulted in...

Zacks Investment Research
ResMed (RMD) Rides On Innovation Amid Reimbursement Woes By Zacks Investment Research - Nov 30, 2017

On Dec 1, 2017, we issued an updated research report on leading medical devices company, ResMed Inc. (NYSE:RMD) . The stock carries a Zacks Rank #3 (Hold).ResMed exited the first quarter of fiscal...

Zacks Investment Research
Apple Set To Witness A "Super Long Cycle" Per Piper Jaffray By Zacks Investment Research - Nov 30, 2017

Apple Inc’s (NASDAQ:AAPL) radically overhauled iPhone X was anticipated to be a super cycle and it seems like it is turning into one.Going a step ahead, Piper Jaffray analyst, Michael Olson in...

Continue with Apple
Continue with Google
or
Sign up with Email